title: Letter by Maesen et al Regarding Article, "Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation".
authors.affiliation: From Departments of Cardio-Thoracic Surgery (B.M., M.L.M.) and Cardiology (L.P.), Maastricht University Medical Center, Maastricht, The Netherlands.
authors.forename: Bart
authors.initials: B
authors.lastname: Maesen
authors.affiliation: From Departments of Cardio-Thoracic Surgery (B.M., M.L.M.) and Cardiology (L.P.), Maastricht University Medical Center, Maastricht, The Netherlands.
authors.forename: Laurent
authors.initials: L
authors.lastname: Pison
authors.affiliation: From Departments of Cardio-Thoracic Surgery (B.M., M.L.M.) and Cardiology (L.P.), Maastricht University Medical Center, Maastricht, The Netherlands.
authors.forename: Mark La
authors.initials: M
authors.lastname: Meir
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D017115:Catheter Ablation; D006801:Humans; D018579:Patient Selection; D016896:Treatment Outcome; D014859:Warfarin
chemical_list: D000925:Anticoagulants; D014859:Warfarin